Major Laboratories and Clinical & Translational Neurosciences Incubator
Showing 81-95 of 95 Results
-
Edith Vioni Sullivan
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
On Partial Leave from 03/02/2026 To 04/06/2026Current Research and Scholarly InterestsApplication of neuroimaging modalities and component process analysis of cognitive, sensory, and motor functions to identify brain structural and functional mechanisms disrupted in diseases affecting the brain: alcohol use disorder, HIV infection, dementia, and normal aging from adolescence to senescence.
-
Martin Tik
Affiliate, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioDr. Tik is a Visiting Scholar at the Stanford Brain Stimulation Lab and Group Leader at the Medical University of Vienna. His research bridges neuroimaging and brain stimulation to uncover mechanisms of therapeutic neuromodulation.
With a background in Biological Psychology and Medical Physics, Dr. Tik has developed innovative methods for integrating Transcranial Magnetic Stimulation with functional Magnetic Resonance Imaging (TMS-fMRI), enabling real-time measurement of stimulation-induced brain activity. His lab (http://tmsfmri.com) advances these tools toward individualized, state-dependent stimulation paradigms and closed-loop applications.
Building on his long-standing collaboration with the Stanford Brain Stimulation Lab, Dr. Tik works closely with Dr. Nolan Williams and colleagues to translate these neurotechnological innovations into clinical research. This ongoing Vienna–Stanford partnership aims to optimize stimulation parameters and dosing strategies for personalized TMS therapy and a better general understanding of brain circuitry in health and disease. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
Gordon Wang
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioGordon Wang received his Bachelors of Arts and Science from the University of California, Davis in 2000 majoring in Comparative literature and Genetics. He received his PhD under Dr. Mu-ming Poo at the University of California, Berkeley in 2005 studying the role of ion channels in mediating neuronal growthcone guidance decisions. As a postdoctoral scholar in the lab of Dr. Stephen Smith at Stanford University, Gordon developed a computational architecture for the detailed study of molecular diversity in synapses and using this system, he studied the diverse role of synaptic diversity in neurodevelopmental diseases, such as fragile x syndrome. In a co-postdoc in Dr. Philippe Mourrain's lab, he studied the dynamic plasticity of synapses in sleep and circadian cycles in larval zebrafish using multi-photon microscopy. The Wang lab focuses on developing imaging tools to deeply analyze proteins, mRNA and lipids at the synapses, and understand how synaptic heterogeneity affect the function of neural circuits throughout development and aging and in diseases such as autism and fragile x syndrome.
-
Leanne Williams
Vincent V.C. Woo Professor and Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Britt Wray
Instructor, Psychiatry and Behavioral Sciences
BioDr. Wray is the Director of CIRCLE at Stanford Psychiatry, a research and action initiative focused on Community-minded Interventions for Resilience, Climate Leadership and Emotional wellbeing in the Stanford School of Medicine. Her research focuses on the mental health impacts of climate change on young people ('emerging adults') and frontline community members, community-minded psychosocial support interventions, and public engagement for improved mental and planetary health. Wray focuses on co-designing and evaluating evidence-based climate distress (climate anxiety/eco-anxiety) interventions with impacted communities and international networks of Integrated Youth Services using a health equity lens, and brings expertise in conceptual models of climate distress, different measurement modalities for climate impact exposures on mental health, community-engaged research, and co-design methods. Previously, Wray was a Human and Planetary Health Postdoctoral Fellow at the Stanford Center for Innovation in Global Health, Stanford Woods Institute for the Environment and London School of Hygiene & Tropical Medicine. She is the author of two books; her latest Generation Dread: Finding Purpose in an Age of Climate Anxiety, is an impassioned generational perspective on how to stay sane amid climate disruption and was a finalist for the 2022 Governor General’s Award. She is the recipient of the 2025 American Climate Leadership Awards (Runner Up), 2023 Canadian Eco-Hero Award and top award winner of the National Academies Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by The National Academies of Sciences, Engineering, and Medicine. Her first book is Rise of the Necrofauna: The Science, Ethics and Risks of De-Extinction (Greystone Books 2017) and was named a "best book of the year" by The New Yorker. Dr Wray holds a PhD in Science Communication from the University of Copenhagen. She has hosted and produced several science radio programs, podcasts and television programs for international broadcasters including the BBC and CBC, and she has spoken at TED and the World Economic Forum. She is the Founder of Unthinkable (unthinkable.substack.com), a newsletter about building courage and taking meaningful action on the far side of climate grief.
-
Natalie M. Zahr
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Major Laboratories)
BioNatalie M. Zahr received a graduate education in the basic sciences including the study of neuro- pharmacology, physiology, and anatomy. After completing her graduate training in electrophysiology, she began a postdoctoral fellowship as a magnetic resonance imaging (MRI) scientist. Her work focuses on translational approaches using in vivo MR imaging and spectroscopy in studies of human with Alcohol Use Disorders (AUD) and in rodent models of alcohol exposure with the goal of identifying mechanisms of alcohol effects on the brain. Her human studies include participants with HIV, those co-morbid for HIV and AUD and recently, aging individuals with mild cognitive impairment (MCI). Her position allows her to explore emerging MR technologies and apply them to test relevant hypotheses. Before joining Stanford, she taught at several local institutions including UC Berkeley extension and Santa Clara University where she enjoyed sharing her knowledge and enthusiasm for learning with students.
-
Yuan Zhang
Basic Life Research Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordBasic Life Research Scientist
